Elsevier

Behavioural Brain Research

Volume 261, 15 March 2014, Pages 114-126
Behavioural Brain Research

Research report
Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice

https://doi.org/10.1016/j.bbr.2013.12.007Get rights and content

Highlights

  • ACPA (i.p.) induce anxiolytic-like behaviors and emotional memory deficit.

  • Intra-BLA injection of Y-25130 reduced emotional memory and locomotor activity.

  • Intra-BLA injection of RS67333 and RS23597 only reduced emotional memory formation.

  • Deactivation of BLA 5-HT3 serotonin receptors are involve in ACPA induced responses.

  • Activation of BLA 5-HT4 serotonin receptors are involve in ACPA induced responses.

Abstract

Background and aim

The critical role of cannabinoidergic and serotonergic systems of the amygdala in modulation of anxiety-like behaviors and emotional memory has already been demonstrated. The present study aimed to investigate the possible role of the basolateral amygdala (BLA) 5-HT3 and 5-HT4 serotonergic systems upon ACPA (CB1 cannabinoid receptor agonist)-induced anxiolytic-like behaviors and emotional memory impairment using the elevated plus-maze (EPM) test-retest paradigm in male mice.

Method

bilateral guide-cannulae were implanted to allow intra-BLA microinjection of serotonergic agents.

Results

the intraperitoneal injection of ACPA could induce anxiolytic-like behaviors and reduce the emotional memory formation. Intra-BLA injection of M-Chlorophenylbiguanide (M-Chl, a 5-HT3 serotonin receptor agonist) neither altered the anxiety-like behaviors nor the emotional memory formation by itself, while the higher dose of Y-25130 (a 5-HT3 serotonin receptor antagonist) reduced the emotional memory formation and locomotor activity but not the anxiety-like behaviors. Furthermore, injection of a higher dose of RS67333 and RS23597 (as 5-HT4 serotonin receptor agonist and antagonist, respectively) did not alter the anxiety-like behaviors, while reduced the emotional memory formation. In addition, the intra-BLA injection of M-Chl but not Y-25130 and RS67333 restored the ACPA-induced anxiolytic-like behaviors and emotional memory deficit, while a higher dose of RS67333 decreased the locomotor activity. Moreover, the intra-BLA microinjection of RS23597 could restore the ACPA-induced anxiolytic-like behaviors but not the emotional memory deficit.

Conclusion

based on our findings, ACPA seems to induce its anxiolytic-like behaviors and emotional memory formation deficits via activation and deactivation of the BLA 5-HT4 and 5-HT3 serotonin receptors.

Introduction

Marijuana and hashish which are derived from hemp plant Cannabis sativa are amongst the most common drugs of abuse worldwide [1]. Based on molecular cloning, two cannabinoid receptors (CB1 and CB2) have been identified [2], [3], however some investigations have introduced an additional cannabinoid receptor type known as non-CB1 and CB2 (CB3) [4], [5]. CB1 cannabinoid receptors are essentially expressed in the central nervous system (such as the basal ganglia, hippocampus, cerebral cortex and amygdala) as well as in peripheral tissues, while CB2 cannabinoid receptors have a predominant peripheral presentation [6]. It seems that the main physiological, cognitive and non-cognitive effects of cannabinoids are induced by central CB1 receptors expressed in various brain regions [7], [8], [9]. Both CB1 and CB2 cannabinoid receptors belong to a seven transmembrane Gi/o-coupled receptor family which share 44% of their protein identity while showing different pharmacological properties [2], [3]. A plethora of research has demonstrated that cannabinoids induce a unique syndrome of cognitive and non-cognitive behavioral effects including the altered anxiety state, short- and long-term memory impairment, the sense of time dilation, mood alterations, enhanced body awareness, reduced ability to focus attention as well as filtering out irrelevant information, discoordination and sleepiness [10], [11], [12], [13], [14], [15], [16], [17]. Several reports have indicated that endogenous cannabinoids (i.e. 2-arachidonoylglycerol and anandamide) are produced at post synaptic level and activate the presynaptic CB1 cannabinoid receptors. This in turn reduces the release of neurotransmitters/hormones including serotonin, GABA, cholecystokinin, corticotropin-releasing factor and opioids [18], [19]. Supported by evidence, CB1 cannabinoid receptors may be considered as an alternative therapeutic target in neuropsychiatric disorders which involve serotonin receptors [20], [21]. Moreover, axon terminals from the serotonergic raphe neurons are endowed with the CB1 cannabinoid receptor in the hippocampus and amygdala [22], suggesting that CB1 cannabinoid receptors may directly control the release of serotonin in such brain regions.

One of the most important neurotransmitters in the central nervous system which involves in several cognitive and non-cognitive behaviors such as mood, sex, appetite, sleep, memory, emotion and anxiety is serotonin [5-hydroxytryptamine (5-HT)]. This neurotransmitter is mainly produced and released from the neurons having their cell bodies in the brainstem raphe nuclei. Today, at least 15 presynaptic and postsynaptic serotonin receptors are identified. Based on these receptors’ structure, their affinity for different ligands, and activation of the secondary messenger, they are classified into seven families (5-HT1-7). Among these receptors, 5-HT3 is the only ligand-gated ion channel receptor with its activation leading to Na+ and Ca2+ influx [23]. This receptor comprises two subunits known as 3A and 3B [24], [25], [26], however the actual mechanism(s) involved with the function of these subtypes are not fully understood [27], [28]. The remaining six subtypes of serotonin receptors are the rhodopsin-like G protein-coupled receptors possessing three extracellular and three intracellular domains with seven transmembrane spanning helices. The 5-HT1, 5-HT2, 5-HT4, 5-HT5, 5-HT6, and 5-HT7 receptors comprise multiple subunits [29]. Moreover, all 5-HT4 receptor isoforms are positively coupled with the adenylyl cyclase enzyme with their activation resulting in cAMP production [30].

Several investigations have strongly supported the critical role of the serotonergic system processes in memory consolidation following one-trial avoidance and conditioned-fear testing paradigms, in which experimental animals have often showed anxiogenic-like behaviors [31], [32], [33], [34]. These effects are thought to be regulated via multiple 5-HT receptor subtypes, thus the behavioral outcomes may notably vary based on the 5-HT receptor subtype involved, the site of administration (central vs. systemic), type of the drugs used, timing of the drug administration, and the behavioral tests employed [35]. 5-HT3 and 5-HT4 serotonin receptors are found in several parts of the brain such as the entorhinal cortex, amygdala and the hippocampus [36], [37], [38], [39], [40]. These receptors which extensively express in the amygdala are shown to play a distinctive role in anxiety-like behaviors, learning and memory processes [29], [37], [39]. As such, 5-HT3 receptor antagonists have demonstrated consistent effects ranging from anxiolytic to anxiogenic behaviors [39], [41], while pharmacological antagonism or knocking out the 5-HT4 gene induces anxiolytic-like behaviors [42].

Amygdala is one of the main brain sites regulating the anxiety state as well as emotional and fear-related memory acquisition [43], [44], [45], [46], [47]. Based on the anatomical studies, amygdala is shown to comprise several distinct nuclei, such as the basal and lateral nuclei (together called basolateral amygdala; BLA) and the central nucleus [48]. BLA is known to modulate anxiety and memory consolidation in a wide variety of the emotionally arousing tasks, irrespective of their positive or negative affective valence [49], [50], [51]. For instance, some investigations have demonstrated that BLA activation and inhibition increases and decreases the anxiety-related physiological and behavioral responses, respectively [52], [53], [54]. Nonetheless, the actual mechanism(s) involved in these phenomena within the BLA remain(s) unclear. It has been postulated that in emotional events, the amygdala regulates the activity of the hippocampal formation. For instance, the activation of amygdala and especially its basolateral region (BLA) in emotionally passive situations potentiates the episodic memory for visual details [55], [56], [57]. Therefore, the integration of amygdala and the hippocampal system seems to play a critical role in emotional memory enhancements [58]. Moreover, in emotional instances such as aversion and fear, this structure may enhance or impair memory formation [59].

Some investigations (i.e. behavioral, physiological, pharmacological, and genetic) have described a close memory-anxiety relationship [60], [61], [62] although this relationship does not follow a consistent synergistic rule. The above suggests that quite a complex nonlinear relation exists between these behavioral functions. Moreover, the fact that altered anxiety is usually seen together with altered memory and vice versa does not oppose with the idea that under certain circumstances both domains may be affected independently. Likewise, memory or anxiety must not be considered as a single entity as each of them clearly represents a complex multidimensional domain on its own [63]. Emotional states (i.e. fear and aversion) can be modulated by enhanced or impaired memory formation [59]. The currently available animal models of learning and memory not only lack the ability to fully detect the effect of drugs on anxiety, fear and memory but also subject to misinterpretation. Using the elevated plus-maze (EPM) test-retest paradigm in rodents is thus an attempt to concomitantly assess the effects of drugs on anxiety, learning and memory [64].

The use of EPM in testing anxiety is based on the natural tendency of animals to avoid dangerous situation when exposed to height and open spaces [65]. In general, animals acquire information with regard to safe and dangerous areas in the maze upon test. Repeated testing in the EPM (usually in 24 h) induces some experience-dependent behavioral changes which possibly represent an index for memory acquisition, consolidation and retention. During re-test, the decreased open arms exploration time may translate to rodents’ acquired emotional learning and memory [66], [67], [68], [69], [70], [71].

Within the BLA, both cannabinoid and serotonin receptors are highly expressed on GABAergic interneurons [72], [73]. Given the involvement of both cannabinoid and serotonin receptors in memory and anxiety function [74], [75], and the fact that cannabinoids directly inhibit the release of serotonin [76], this study was designed to examine the functional interaction between BLA serotonin (5-HT3 and 5-HT4) receptors upon ACPA (selective CB1 cannabinoid receptor agonist)-induced emotional amnesia in EPM test-retest protocol in mice.

Section snippets

Animals

Adult (8–9 weeks of age) male white mice (Institute for Cognitive Science Studies; Tehran, Iran) weighting 28–33 g at the time of surgery were used. Animals were housed in a colony, maintained at 22 ± 2 °C with a 12-h light/12-h dark cycle (lights on at 07:00 h) and allowed free access to food and water inside the standard polypropylene cages. Eight animals were used in each experimental group. The experiments were carried out during the light phase of the cycle. Animals handling was limited to the

Effects of the pretest intra-BLA microinjection of M-Chl on the open-arms exploratory behaviors

Repeated measure and post hoc analysis between test and retest days showed that intra-BLA injection of M-Chl at applied doses did not alter the transfer latency [Intra-groups: F(3, 24) = 1.1, P > 0.05, Inter-groups: F(1, 24) = 35.6, P < 0.001, Inter-Intra groups interaction: F(3, 24) = 0.99, P > 0.05; Fig. 1, panels 1A and 2A], %OAT [Intra-groups: F(3, 24) = 1.75, P > 0.05, Inter-groups: F(1, 24) = 48.9, P < 0.001, Inter-Intra groups interaction: F(3, 24) = 1.56, P > 0.05; Fig. 1, panels 1B and 2B], %OAE

The effects of ACPA on open-arms exploratory behaviors in naive mice subjected to EPM

Present results indicate that the intra-peritoneal infusion of the selective CB1 cannabinoid receptor agonist, ACPA, elicits the anxiolytic-like effects. Furthermore, anxiolytic-like effects of ACPA emerge into the retest session. These results confirmed the impairment of aversive memory acquisition in ACPA-treated animals upon test. Meanwhile, the drug did not alter the locomotor activity on test and retest days.

In terms of anxiety-like behaviors, the effects of cannabinoid agonists on this

Acknowledgements

The authors thank the Iran National Science Foundation (INSF) for providing financial support to this project.

References (159)

  • A.G. Hope et al.

    Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit

    Eur J Pharmacol

    (1993)
  • J.A. van Hooft et al.

    5-HT3 receptors in the CNS: 3B or not 3B

    Trends Pharmacol Sci

    (2003)
  • T. Inoue et al.

    Effect of conditioned fear stress on serotonin metabolism in the rat brain

    Pharmacol Biochem Behav

    (1993)
  • T. Inoue et al.

    Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain

    Pharmacol Biochem Behav

    (1994)
  • S.O. Ogren et al.

    The role of 5-HT(1A) receptors in learning and memory

    Behav Brain Res

    (2008)
  • J.M. Barnes et al.

    Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat

    Neuropharmacology

    (1990)
  • J. Hannon et al.

    Molecular biology of 5-HT receptors

    Behav Brain Res

    (2008)
  • B. Olivier et al.

    5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

    Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol

    (2000)
  • G.A. Kennett et al.

    Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats

    Neuropharmacology

    (1997)
  • A.H. Lichtman et al.

    Endocannabinoids in cognition and dependence

    Prostaglandins Leukot Essent Fatty Acids

    (2002)
  • K. Tsou et al.

    Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation

    Neuroscience

    (1999)
  • M.R. Zarrindast et al.

    Influence of nitric oxide agents in the rat amygdala on anxiogenic-like effect induced by histamine

    Neurosci Lett

    (2011)
  • T.J. Sajdyk et al.

    Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test

    Brain Res

    (1997)
  • S.K. Sanders et al.

    Regulation of anxiety by GABAA receptors in the rat amygdala

    Pharmacol Biochem Behav

    (1995)
  • W.A. Truitt et al.

    Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala

    Neuroscience

    (2009)
  • F. Dolcos et al.

    Interaction between the amygdala and the medial temporal lobe memory system predicts better memory for emotional events

    Neuron

    (2004)
  • M. Barad

    Fear extinction in rodents: basic insight to clinical promise

    Curr Opin Neurobiol

    (2005)
  • P.M. Wall et al.

    Concurrent modulation of anxiety and memory

    Behav Brain Res

    (2000)
  • L. Asth et al.

    The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice

    Brain Res Bull

    (2012)
  • M.R. Zarrindast et al.

    The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response

    Neurosci Lett

    (2010)
  • L.J. Bertoglio et al.

    Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety

    Behav Brain Res

    (2000)
  • C. Fernandes et al.

    The influence of open arm ledges and maze experience in the elevated plus-maze

    Pharmacol Biochem Behav

    (1996)
  • A.C. Gianlorenco et al.

    Microinjection of histamine into the cerebellar vermis impairs emotional memory consolidation in mice

    Brain Res Bull

    (2011)
  • C.A. Stern et al.

    Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest

    Neuroscience

    (2010)
  • D. Treit et al.

    Anxiogenic stimuli in the elevated plus-maze

    Pharmacol Biochem Behav

    (1993)
  • H. Hermann et al.

    Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain

    Neuroscience

    (2002)
  • A. Meneses

    Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2 C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory

    Behav Brain Res

    (2007)
  • J.E. Ortega et al.

    Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat

    Neuropharmacology

    (2012)
  • B. Yousefi et al.

    Involvement of the CA1 GABAA receptors in ACPA-induced impairment of spatial and non-spatial novelty detection in mice

    Neurobiol Learn Memory

    (2013)
  • K.R. Serafim et al.

    H(1)-histamine receptors in the amygdala are involved in emotional memory but do not mediate anxiety-related behaviors in mice submitted to EPM testing

    Brain Res Bull

    (2012)
  • M.R. Zarrindast et al.

    Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice

    Behav Brain Res

    (2012)
  • H. Ahmadi et al.

    Involvement of the nucleus accumbens shell dopaminergic system in prelimbic NMDA-induced anxiolytic-like behaviors

    Neuropharmacology

    (2013)
  • T. Motevasseli et al.

    Role of ventral hippocampal NMDA receptors in anxiolytic-like effect of morphine

    Physiol Behav

    (2010)
  • L.J. Bertoglio et al.

    Further evidence that anxiety and memory are regionally dissociated within the hippocampus

    Behav Brain Res

    (2006)
  • S.E. File

    The interplay of learning and anxiety in the elevated plus-maze

    Behav Brain Res

    (1993)
  • S. Pellow et al.

    Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

    J Neurosci Methods

    (1985)
  • I.C. Da Cunha et al.

    The role of nitric oxide in the emotional learning of rats in the plus-maze

    Physiol Behav

    (2005)
  • A. Holmes et al.

    Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state

    Pharmacol Biochem Behav

    (1998)
  • A.P. Carobrez et al.

    temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on

    Neurosci Biobehav Rev

    (2005)
  • M.R. Lamprea et al.

    Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms

    Behav Brain Res

    (2000)
  • Cited by (46)

    • The effect of GABA-B receptors in the basolateral amygdala on passive avoidance memory impairment induced by MK-801 in rats

      2021, Behavioural Brain Research
      Citation Excerpt :

      Amygdala, with all its areas including the central amygdala (CeA), the basolateral amygdala (BLA), the basomedial amygdala (BMA), and the medial amygdaloid (MeA) nuclei, plays a main role in regulating memory [19]. The BLA has a key role in emotional and motivational learning and memory in mice [20]. Previous study has shown that the BLA significantly affects synaptic plasticity [21].

    • Endocannabinoid-serotonin systems interaction in health and disease

      2021, Progress in Brain Research
      Citation Excerpt :

      It has been shown that 5-HT3 receptor activation, which does not affect anxiety in wild-type mice, reverses the increased anxiety behavior displayed by mice with genetically disrupted CB1 receptors (Mikics et al., 2009). In marked contrast, administration of the subthreshold dose of a 5-HT3 receptor agonist in the BLA reverses the anxiolytic-like effects and the aversive memory impairment induced by systemic activation of the CB1 receptor (Chegini et al., 2014). These apparent contrasting effects can be explained by the fact that both CB1 and 5-HT3 receptors are co-expressed on cholecystokinin-containing GABAergic terminals in the basolateral amygdala, hippocampus, and PFC where they oppositely regulate GABA release.

    View all citing articles on Scopus
    View full text